Date | Time | Source | Headline | Symbol | Company |
04/11/2024 | 11:17AM | PR Newswire (Canada) | L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
04/11/2024 | 11:17AM | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
04/11/2024 | 11:08AM | PR Newswire (Canada) | Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BHC | TSX:BHC | Bausch Health Companies Inc |
04/11/2024 | 11:03AM | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
04/03/2024 | 12:08PM | PR Newswire (Canada) | L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
04/03/2024 | 12:05PM | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
04/03/2024 | 12:04PM | PR Newswire (Canada) | Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BHC | TSX:BHC | Bausch Health Companies Inc |
04/03/2024 | 12:01PM | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
11/01/2023 | 10:44AM | PR Newswire (Canada) | L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
11/01/2023 | 10:43AM | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
11/01/2023 | 10:43AM | PR Newswire (Canada) | Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BHC | TSX:BHC | Bausch Health Companies Inc |
11/01/2023 | 10:40AM | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
05/31/2023 | 8:00AM | PR Newswire (US) | OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease | TSX:BHC | Bausch Health Companies Inc |
05/17/2023 | 1:34PM | PR Newswire (Canada) | L'OCRCVM permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
05/17/2023 | 1:33PM | PR Newswire (Canada) | IIROC Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
05/17/2023 | 1:18PM | PR Newswire (Canada) | Suspension de la négociation par l'OCRCVM - BHC | TSX:BHC | Bausch Health Companies Inc |
05/17/2023 | 1:17PM | PR Newswire (Canada) | IIROC Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
05/17/2023 | 12:47PM | PR Newswire (Canada) | L'OCRCVM permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
05/17/2023 | 12:46PM | PR Newswire (Canada) | IIROC Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
05/17/2023 | 12:44PM | PR Newswire (Canada) | Suspension de la négociation par l'OCRCVM - BHC | TSX:BHC | Bausch Health Companies Inc |
05/17/2023 | 12:43PM | PR Newswire (Canada) | Suspension de la négociation par l'OCRCVM - BHC | TSX:BHC | Bausch Health Companies Inc |
05/17/2023 | 12:43PM | PR Newswire (Canada) | ttIIROC Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
05/17/2023 | 12:41PM | PR Newswire (Canada) | IIROC Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
05/03/2023 | 6:58AM | PR Newswire (Canada) | RYALTRIS®, a new combination prescription nasal spray for moderate to severe seasonal allergic rhinitis (SAR), now available across Canada | TSX:BHC | Bausch Health Companies Inc |
05/03/2023 | 6:58AM | PR Newswire (Canada) | RYALTRIS(MD), une nouvelle association sous ordonnance en pulvérisateur nasal pour la rhinite allergique saisonnière (RAS) d'intensité modérée à grave, est maintenant disponible partout au Canada | TSX:BHC | Bausch Health Companies Inc |
12/22/2022 | 6:59AM | PR Newswire (Canada) | First tazarotene lotion treatment for acne vulgaris, ARAZLO™ (tazarotene lotion, 0.045%), now available to patients through Quebec, Ontario, Alberta, Saskatchewan and federal NIHB public drug plans | TSX:BHC | Bausch Health Companies Inc |
12/22/2022 | 6:59AM | PR Newswire (Canada) | ARAZLOMC (lotion de tazarotène, 0,045 %), la première lotion à base de tazarotène indiquée pour le traitement de l'acné vulgaire, est maintenant offerte aux patients du Québec, de l'Ontario, de l'Alberta et de la Saskatchewan dans le cadre des régi | TSX:BHC | Bausch Health Companies Inc |
11/17/2022 | 1:08PM | PR Newswire (Canada) | L'OCRCVM permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
11/17/2022 | 1:06PM | PR Newswire (Canada) | IIROC Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
11/17/2022 | 1:04PM | PR Newswire (Canada) | Suspension de la négociation par l'OCRCVM - BHC | TSX:BHC | Bausch Health Companies Inc |